
In this episode, I’m joined by my longtime friend Ian Simon, Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to senior roles at the White House, HHS, NIH, the State Department, and the Office of Long Covid. We talk about de-risking young biotech companies, what Covid taught us about science and public health, and how new technologies like AI might change how we do science altogether. TPM E52 highlights >Episode 52 links:Ian Simon on LinkedInAspis Intelligence
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Jacob Hooker | From motifs to medicines: Harnessing nature’s pharmacopeia for novel CNS therapies | TPM podcast #59

James Zanewicz | Fostering innovation at scale: it’s all about the ecosystem | TPM podcast #58

Lisa Gurry | To Infinity and beyond: the future of comprehensive testing and genetic medicine | TPM podcast #57

Kamal Jethwani | The concierge CEO: Incubating the next generation of digital oncology companies | TPM podcast #56
Free AI-powered recaps of Talking Precision Medicine and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.